chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a consumer concerning her son who, "4 weeks ago", on approximately 13-JAN-2009, was vaccinated with a dose of ATTENUVAX. More than 2 weeks later, her son was vaccinated with a dose of MUMPSVAX. On approximately 10-FEB-2009 the child had a "stomach virus". The patient visited the physician for it. The consumer reported that her pediatrician routinely gave the monovalents on a 2 weeks spacing interval to all children in the practice. At the time of this report, the outcome was unknown. Additional information is not expected.
So basically, I started to notice pulsatile tinnitus in my right ear. I consulted a specialist over the phone, and she believes it might have been Otosclerosis, no test has been run yet but my primary doctor noticed inflammation in my right ear canal. I don't think its related to the virus, but I noticed it.
No additional adverse events reported.; Medical Assistant reporting the administration of expired VAQTA and inquiring viability of the administration of expired dose.; This spontaneous report was received from a medical assistant, referring to a patient of unknown age and gender. Information regarding the patient's concurrent conditions, concomitant medications pertinent medical history or drug reactions/allergies was not provided.  On 18-APR-2022, the patient was vaccinated with an expired dose of hepatitis a vaccine, inactivated (VAQTA) pre-filled syringe, dose of 1 mL, lot number: U004367 was confirmed to be valid, expiration date: 11-APR-2022 (route of administration and anatomical location were not reported) for prophylaxis (expired product administered). No additional adverse events reported (no adverse event). No product quality complaints reported. No further details were provided.
Patient tolerated well no adverse reaction, dose given after moderna bivalent vial was in fridge longer than 30 days.
Irregular menstrual bleeding. I contacted my PCP and was referred to an OBGYN after the initial irregular bleeding. All tests and procedures came back ?normal? so I have yet to get an answer as to why this is happening. My doctor agreed that it my be vaccine related after concluding she could find no other cause. It has been happening every month, sometimes more than once since my second covid vaccine.
In the last 48 hours, have you had a fever* OR symptoms that are unrelated to a preexisting illness?: New cough, New change or loss of taste sensation, New loss of smell, New muscle aches
This report is concerning a 42 month old male who on an unspecified date was vaccinated with 1 dose of MMRII and Hib conjugate vaccine (mfr unk), Hep-B vaccine, recomb (Engerix-B), diphtheria toxoid/pertussis vaccine/teta (mfr unk), poliovirus vaccine (IPOL) and tuberculin purified protein derivative (PPD Tine Test). At 3.5 years of age, in approx. 12/01, the pt had a delay in the ability to speak and had a vocabulary of approx. 12 words. It was reported that the child "was evaluated by the local school district, which stated that the child shows signs of autism and that can be caused by mercury poisoning". It was reported that the pt had not been evaluated by a physician. This was originally reported by the pt's father. Upon internal review, the pt's autism and mercury poisoning were considered to be "Other Important Medical Events". Additional information has been requested.
Headache, Myalgia, Arthralgia, Diarrhea, NauseaVomiting chills, fatigue Narrative:
pt recv vax 25SEP97 & immed p/vax pt exp tenderness, swelling, redness & warmth @ the inj site;
Swelling node /left armpit area; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 27Apr2021 11:00 (Lot number: EW0170) at the age of 39 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "No" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (dose 1, lot number=EP7533, administration time=11:45 AM, vaccine location=Left arm), administration date: 06Apr2021, for COVID-19 immunization. The following information was reported: LYMPHADENOPATHY (non-serious) with onset 28Apr2021 11:00, outcome "recovering", described as "Swelling node /left armpit area". Therapeutic measures were taken as a result of lymphadenopathy.  Additional information: No other vaccine in four weeks. AE treatment: Ibuprofen. No COVID prior vaccination. No COVID tested post vaccination:  No  No follow-up attempts are possible. No further information is expected.
swelling of the throat; neck itching; This spontaneous case was reported by a consumer and describes the occurrence of PHARYNGEAL SWELLING (swelling of the throat) and PRURITUS (neck itching) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PHARYNGEAL SWELLING (swelling of the throat) and PRURITUS (neck itching). At the time of the report, PHARYNGEAL SWELLING (swelling of the throat) and PRURITUS (neck itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment and concomitant medicines were not reported
Later that night after getting the shot her arm felt stiff and she could barely move it and her joint is very stiff. She has tried taking advil and she's also tried icing her arm.
TACHYCARDIA; SLIGHTLY LOW WHITE BLOOD CELL COUNT; CHEST PAIN; BLOODY NOSE; HIVES IN BACK (RED AND ELEVATED); ACHINESS; PRE MENSTRUAL BLEEDING; NAUSEA; FATIGUE; HEADACHE; MINOR CHILLS; This spontaneous report received from a physician concerned a patient. The patient's height, and weight were not reported. The patient's concurrent conditions included alcohol user, and non-smoker, and other pre-existing medical conditions included the patient had no known allergies and relatively healthy individual. the patient was not pregnant at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose was not reported, administered on 25-MAR-2021 07:00 at left arm for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAR-2021, Laboratory data included: Chest X-ray (NR: not provided) Normal, and ECG (NR: not provided) Normal. On 25-MAR-2021, the subject experienced minor chills. On 25-MAR-2021, the subject experienced fatigue. On 25-MAR-2021, the subject experienced headache. On 26-MAR-2021, the subject experienced achiness. On 26-MAR-2021, the subject experienced pre menstrual bleeding. On 26-MAR-2021, the subject experienced nausea. Laboratory data included: Heart rate (NR: not provided) 69 {beats}/min. On 27-MAR-2021, the subject experienced tachycardia. On 27-MAR-2021, the subject experienced slightly low white blood cell count. On 27-MAR-2021, the subject experienced chest pain. On 27-MAR-2021, the subject experienced bloody nose. On 27-MAR-2021, the subject experienced hives in back (red and elevated). Laboratory data included: Decreased hemoglobin (NR: not provided) 1.9 (unspecified unit), Heart rate (NR: not provided) 90 {beats}/min, 106 {beats}/min, and White blood cell count (NR: not provided) 3.6 (unspecified unit). Treatment medications (dates unspecified) included: diphenhydramine hydrochloride. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chest pain on 29-MAR-2021, achiness, bloody nose, hives in back (red and elevated), and fatigue on 27-MAR-2021, and pre menstrual bleeding, minor chills, and headache on 28-MAR-2021, was recovering from tachycardia, and the outcome of slightly low white blood cell count and nausea was not reported. This report was non-serious.; Sender's Comments: V0:  Medical Assessment comment not required as per standard procedure as the case assessed as non-serious.
Myalgia, Arthralgia, NauseaVomiting,  malaise Narrative:
Menstrual spotting around 8:30pm the same day of vaccine injection. This was outside of my menstrual cycle. Occurred 1 time.
The vaccine given past refrigeration expiration date. The date on the vial still within date. Antibody testing completed.
Fever; Shoulder pain; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and ARTHRALGIA (Shoulder pain) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced PYREXIA (Fever) and ARTHRALGIA (Shoulder pain). At the time of the report, PYREXIA (Fever) and ARTHRALGIA (Shoulder pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported  No treatment information was provided.
This spontaneous report was received from a pharmacist concerning a patient of unknown age and gender. There was no information about the patient's concurrent conditions, medical history or concomitant medication. On 14-SEP-2016, the patient was vaccinated with ZOSTAVAX 19400 plaque-forming unit (PFU) for prophylaxis (route of administration, lot number and expiration date were not reported). On 31-OCT-2017, the patient received another separate dose of ZOSTAVAX 19400 plaque-forming unit (PFU) lot # N020938 with expiration date of 31-JUL-2018, for prophylaxis (route of administration was not reported). Vaccines were reconstituted with sterile diluent (MERCK). No adverse events were reported.
herpes zoster/ shingles; This spontaneous report was received from a lawyer and refers to a male patient of unknown age. The patient's concurrent conditions, medical history and concomitant medications were not reported.  On or about 24-AUG-2017, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (dose, route of administration, anatomical location, lot number and expiry date were not provided) for routine health maintenance and the prevention of shingles (herpes zoster). On 28-AUG-2017 (reported as four days after receiving the vaccine), the patient suffered herpes zoster/shingles. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient's symptoms resulted in physical limitations not present prior to using vaccine. The patient also experience mental and emotional distress due to resulting physical limitations and seriousness of patient's condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), the pt sustained severe and permanent personal injuries. Further, the pt suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of zoster vaccine live (ZOSTAVAX) use, the patient suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages.  The reporter considered herpes zoster/ shingles to be related to zoster vaccine live (ZOSTAVAX).  The event of herpes zoster/ shingles was considered to be disabling.
muscle pain; whole body hurts; This case was reported by a consumer via call center representative and described the occurrence of muscle pain in a 60-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On 29th May 2019, the patient received Shingrix. On an unknown date, less than a week after receiving Shingrix, the patient experienced muscle pain and general body pain. The patient was treated with ibuprofen (Advil). On an unknown date, the outcome of the muscle pain and general body pain were unknown.   It was unknown if the reporter considered the muscle pain and general body pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient expereienced a listed side effects  as muscle pain.  The patient's whole body hurts and asked how long would  the side effects last. The patient took 2 Advil about 20 minutes ago from the repoerting date. The muscle pain didn't concern the patient and just want to know how long it's going to last.
i cant even lift that arm,hurt; i cant even lift that arm; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (i cant even lift that arm,hurt) and MOVEMENT DISORDER (i cant even lift that arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (i cant even lift that arm,hurt) and MOVEMENT DISORDER (i cant even lift that arm). At the time of the report, PAIN IN EXTREMITY (i cant even lift that arm,hurt) and MOVEMENT DISORDER (i cant even lift that arm) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications reported. No treatment medication reported.  Patient submitted AE and stated that he was told to come back in if his arm continued to hurt after 24 hours. He stated that it's almost that time, and he can't even lift that arm.   Reporter did not allow further contact
Patient stated he felt hot and dizzy. Gave patient cool compresses to hold on his head. Patient felt fine and was able to go home.
Bruising and pain in left arm. Started almost two hours after receiving shot. Spoke to MD at an already scheduled apt. Still has some bruising.
Pt vaccinated Pneumovax developed Lt arm local swelling, lt elbow arthritis & pain -joint erythema, headache, weakness, unsteady gait. No other neurologic abnormalities.
Rash appeared on left neck. Red, not itchy at first and went away until after second shot March 2, 2021. Then it appeared again a few weeks later larger and very itchy.
The pt received her 1st injection of Engerix-B on an unspecified date; she had no adverse experience following receipt of this injection. She received her 2nd injection of Engerix-B and her 1st injection of Havrix on 3/20/00. An unspecified time, post vax, the pt was hospitalized due to pain in her liver, "her bilirubin being so high", and dehydration. The physician reportedly stated, "her liver is that of a geriatric pt". As of 10/23/01, the inflammation of the liver persisted. The outcome of the dehydration was not specified. The most recent info was received on 12/3/01. The pt's mother reported that the pt had been "really, really ill" and had been "in the hospital five out fo the last ten days." The mother reported that the pt's physicians "say there is no relationship" between the vaccines administered and the inflammation of the liver.
Post vaccine pt became dizzy and c/o heart palpitations. Pt was transported to obs at 1515 via wc. Vitals obtained and monitored. Symptoms resolved. Pt released home with daughter at 1549. Vitals as follows: 1518 LYING BP 151/94 HR 60 RR 16 SPO2 99 1524 LYING BP 133/84 HR 63 RR 16 SPO2 97 1527 LYING BP 147/99 HR 70 SPO2 99 1537 SITTING BP 145/89 HR 76 RR 18 SPO2 99 1543 STANDING BP 146/63 HR 75 RR 18 SPO2 98
Patient received Pfizer as a second dose and the patient had received Moderna as their first dose. Patient shared that they had received Pfizer as their first dose.
Rash, clumsy, irritable, screaming, 3 days after measles (varicella given, not MMR).
This spontaneous report was received from an epidemiologist referring to unspecified patients of unknown age and gender. The patients' medical history, concomitant therapy and drug reactions were not reported. On unspecified dates, the patients were vaccinated with doses of improperly stored (incorrect product storage) VARIVAX (Merck) (dose and route unspecified) (lot# L024255, expiration date 01-JUL-2017, lot# 01-JUL-2017, lot# L026405, expiration date 15-JUL-2017). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
minor soreness at the injection site; minor tenderness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (minor soreness at the injection site) and VACCINATION SITE PAIN (minor tenderness at the injection site) in a 93-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concurrent medical conditions included Cholesterol and Glaucoma. Concomitant products included IBUPROFEN for Pain.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (minor soreness at the injection site) and VACCINATION SITE PAIN (minor tenderness at the injection site). At the time of the report, VACCINATION SITE PAIN (minor soreness at the injection site) and VACCINATION SITE PAIN (minor tenderness at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant information provided. No treatment information provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
My left arm is extremely sore.  Not able to lift my arm high and not able to sleep on my left side.
About 12 hours after given dT and Hepatitis A vaccine developed urticaria and slight throat discomfort. Seen in ER and started on P.O. steroid and Benadryl.
This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (injection site itchy bump) and VACCINATION SITE RASH (Full blown rash around the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. No medical history was reported by the reporter. Concomitant products included DIPHENHYDRAMINE, PARACETAMOL (TYLENOL), Diphenhydramine cream and arnica gel for an unknown indication. On Nov-1950, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (injection site itchy bump) and VACCINATION SITE RASH (Full blown rash around the injection site). At the time of the report, VACCINATION SITE PRURITUS (injection site itchy bump) and VACCINATION SITE RASH (Full blown rash around the injection site) outcome was unknown. Not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Information has been received form a 23 year old female physician with hypercholesterolemia, and allergies to penicillin and cephalosporin, who "about 2 weeks" prior to the report, on approximately 27-SEP-2006 was vaccinated SC with one dose of Varivax. Concomitant therapy included prenatal vitamins, though she reported that she is not pregnant. On 09-OCT-2006, the patient developed 20 vesicular, itchy lesions on her body. Medical attention was sought. It was reported that lab studies were not performed at the time of the report but that varicella titers were measured twice and negative for antibodies prior to vaccination. No further details were available. There was no product quality complaint involved. Additional information has been requested.
I experienced what I felt was a panic attack a little over two days after I received my second dose of Moderna.  I had shortness of breath, mind fogginess, chest pressure, and dizziness when standing up.  It didn't seem to go away fully that night as I went to bed with slight shortness of breath and I woke up with chest pressure the next morning.  I continued to have slight chest pressure/pains that came & went as well as a bad headache so I went to go see my doctor.  He suggested that it was from anxiety & side effects from the shot since I had Covid in March of 2020.  I still have chest pressure/pain and headache that comes and goes.
This spontaneous report was received from a registered nurse and refers to two unspecified patients of unknown age and gender. The patients' concurrent conditions and medical histories were not reported. In approximately 2016 (reported as "on unspecified dates starting in March 2016"), the patients were each vaccinated with unspecified improperly stored doses of ROTATEQ oral liquid, orally, which had a lot # of K013868, an expiration date of 27-MAY-2016 (concentration and dose were not reported). Which were exposed to a temperature of 32.4 F for a time frame of 1 h and 15 minutes, without a previous excursion. Additionally, a data logger was involved. Information regarding concomitant therapies was not reported and no product quality complaint was involved. No adverse effect reported. This is one of two reports from the same reporter. Additional information has been requested.
temp >104, inc lethargy, irritability, would not ambulate;seen @ clinic & given APAP w/codeine;
On 11/11/21 Patient was inadvertently given pediatric dose of Pfizer even though she was 12 years old. Mother was notified and informed that she would need to restart the series with the adult Pfizer dose. and to come back in that evening. Mother wanted to speak with pediatrician. On 12/2/21 mother and patient came back in and after speaking with pediatrician she was advised to stay with the pediatric dose. Based on mother's request the pediatric dose was given.
Day 1 and 2&3 extreme Unmanageable fatigue chills all over body ache Weakness in both legs.  Covid arm symptoms began on Day 6 arm began itching at site of injection. Day 7 arm itchy red large hard swelling at site of injection painful to touch
No adverse effect noted. Resident received expired booster Moderna vaccine, expired on 10/13/2021.
Information has been received from a physician concerning a 36 year old white female who in July 2000, was vaccinated with varicella virus vaccine live. Four weeks later, the pt experienced angioedema and hives. It was reported that since that time, each week on the same day of the week, Thursday, the pt experienced hives. It was noted that since approx. 10/00, the pt has also experienced slight laryngeal edema. Also, it was reported that the pt feels that since the vaccination in July 2000, she has experienced an increase in her "mild asthma". Unspecified medical attention was sought. Follow-up information from the physician, indicated that the pt was vaccinated with the 1st dose of varicella on 7/20/00. It was reported that there was no illnesses at the time of vaccination. On 8/20/00, the pt developed generalized hives, lip angioedema, ankle and shoulder swelling, and a mild worsening of asthma. No improvement was seen with aggressive antihistamine therapy. The pt developed laryngeal edema and was placed on oral steroids with good response. The physician considered the events life threatening and "Other Medical Events". As of 11/14/00, the pt recovered from the events. No further details were provided.
Hives, Rash, itching, chest tightness, throat tightness, dry mouth, difficulty breathing
Erythemia, swelling 10 x 6cm stating 6 days after.